%20rotate(-90)'%3e%3ccircle%20id='Ellipse_7'%20data-name='Ellipse%207'%20cx='2.5'%20cy='2.5'%20r='2.5'%20transform='translate(360.051%208.679)'%20fill='%23ff3000'/%3e%3ccircle%20id='Ellipse_8'%20data-name='Ellipse%208'%20cx='2.5'%20cy='2.5'%20r='2.5'%20transform='translate(360.051%2016.679)'%20fill='%23ff3000'/%3e%3ccircle%20id='Ellipse_9'%20data-name='Ellipse%209'%20cx='2.5'%20cy='2.5'%20r='2.5'%20transform='translate(360.051%2024.679)'%20fill='%23ff3000'/%3e%3c/g%3e%3c/svg%3e)
Minding the business
When AI Search Gets Poisoned: Pharma Marketing and the New Spam Wars
As AI search and agentic tools replace traditional search, brands are learning how to poison the answer layer itself via user‑generated platforms, and forcing responsible marketers to choose between ethical GEO and weaponized AEO.
Healthcare. Agency.
Healthcare is changing faster than pharma communications can track. Agencies that understand the wider system will define what comes next.
Real Strategy Is Returning
Strategy isn’t evolving. It’s returning to a rigorous, reality-based practice, especially in healthcare where context, systems, and real impact matter.
Rethinking Brand Recall in Pharma
Rethinking pharma brand recall: why HCPs need retrieval cues, patients need identity signals, and effective creative must bridge both in shared treatment decisions.
Psychedelic-Assisted Therapy and the Question of Legitimacy
Psychedelic therapies are nearing approval, but adoption will hinge on more than clinical data. Explore how cultural legitimacy, history, and public perception will shape the future of psychedelic medicine.
Zebra was the start—it’s time to reveal the zeals
Healthcare marketers can make rare diseases less rare by pursuing bolder collaborations, sharper creative, and bigger wins for underserved communities.
Why Shiny Tools Keep Replacing Understanding
Shiny tools are easy to sell, but they often replace the harder work of understanding people. When marketing treats technology as a shortcut to insight, complexity grows and clarity fades. Real progress comes from attention, judgment, and experience, with technology earning its role by supporting human understanding rather than standing in for it.
2026: Making Meaningful Connections in Pharma
Pharma connection is a context problem, not a content one. Why 2026 demands faster learning, practical clarity, and connection-first strategy for patients and HCPs.